Intratumoral interleukin-9 delineates a distinct immunogenic class of gastric cancer patients with better prognosis and adjuvant chemotherapeutic response

Intratumoral interleukin-9 delineates a distinct immunogenic class of gastric cancer patients with better prognosis and adjuvant chemotherapeutic response

Interleukin-9 (IL-9) is a T cell cytokine that is associated with inflammation and allergy, but the expression level of IL-9 in gastric cancer and its clinical significance are less well established. Our study aims to uncover the critical role of IL-9 in the progression of gastric cancer. Here, a to...

Full description

Bibliographic Details
Main Authors: H. Fang, R. Li, Y. Gu, Yuchao Fei, Kaifeng Jin, Yifan Chen, Yifan Cao, Xin Liu, Kunpeng Lv, Jieti Wang, Kuan Yu, Chao Lin, Hao Liu, He Li, Hongyong He, Weijuan Zhang, Heng Zhang, Zhenbin Shen
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:OncoImmunology
Subjects:
gastric cancer
interleukin-9
prognosis
adjuvant chemotherapy
immunotherapy
Online Access:http://dx.doi.org/10.1080/2162402X.2020.1856468

Internet

http://dx.doi.org/10.1080/2162402X.2020.1856468

Similar Items